AMN Healthcare posts $188 million Q4 loss on $222 million goodwill impairment
AMN Healthcare reported fourth quarter 2024 revenue of $735 million, down 10% from a year earlier, and a net loss of $188 million, or $4.90 per diluted share, driven by a $222 million non-cash goodwill impairment. The company also guided first quarter 2025 revenue to $660 million to $680 million, which it said is 17% to 20% lower than the year-ago period.
Key points
- Q4 2024 revenue was $735 million, down 10% year over year; full year 2024 revenue was $2.98 billion, down 21%.
- Q4 2024 GAAP net loss was $188 million ($4.90 per diluted share), versus net income of $12 million a year earlier, due to a $222 million goodwill impairment.
- Adjusted diluted EPS was $0.75 in Q4 2024, compared with $1.32 a year earlier.
- First quarter 2025 guidance calls for consolidated revenue of $660 million to $680 million and an adjusted EBITDA margin of 7.7% to 8.2%.
The filing
Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.